increasingli
use
hear
lose
therapeut
util
antibiot
due
resist
good
hear
antibiot
longitud
prize
follow
public
vote
longitud
prize
award
follow
competit
scheme
research
group
prompt
innov
develop
novel
bacteri
diagnost
howev
novel
diagnost
one
strategi
need
develop
come
toward
end
antibiot
discuss
lancet
id
focus
need
global
respons
global
problem
antibiot
resist
follow
recent
report
lancet
infecti
diseas
commiss
novel
antibiot
anoth
import
need
random
control
studi
new
england
journal
medicin
nejm
evalu
two
new
glycopeptid
antibiot
treat
bacteri
skin
infect
singl
intraven
dose
oritavancin
noninferior
twice
daili
intraven
vancomycin
seven
day
similarli
one
weekli
intraven
dose
dalbavancin
noninferior
daili
vancomycin
follow
linezolid
clearli
singl
weekli
dose
antibiot
prefer
number
reason
least
patient
conveni
discoveri
truli
novel
antibiot
limit
fact
potenti
bacteri
target
cover
agent
new
insight
construct
outer
membran
lipopolysaccharid
publish
natur
could
spur
novel
drug
discoveri
anoth
approach
augment
activ
exist
antibiot
research
journal
antimicrobi
chemotherapi
report
addit
anthracyclin
antibiot
isol
streptomyc
sensit
gramneg
bacteria
activ
rifampicin
relat
approach
interrupt
quorum
sens
bacteria
attenu
virul
studi
plo
pathogen
demonstr
small
molecular
inhibitor
savirin
select
inhibit
agrbas
quorum
sens
staphylococcu
aureu
without
disrupt
staphylococcu
epidermidi
use
chemic
prophylaxi
treatment
wound
reduc
burden
antibiot
use
random
control
trial
infect
control
hospit
epidemiolog
ich
found
surgic
site
infect
common
use
nasal
povidoneiodin
vs
nasal
mupirocin
prophylaxi
studi
journal
infecti
diseas
demonstr
antimicrobi
blue
light
therapi
multidrugresist
acinetobact
baumannii
effect
mous
burn
model
may
futur
option
prophylaxi
treatment
burn
sever
studi
identifi
unnerv
level
antibiot
effluent
pharmaceut
factori
develop
market
india
howev
studi
river
sediment
midland
uk
publish
journal
antimicrobi
chemotherapi
report
import
esbl
gene
introduc
wast
water
treatment
plant
furthermor
studi
report
carbapenemresist
escherichia
coli
isol
river
sampl
similar
data
also
report
recent
franc
need
stop
pollut
planet
antibiot
way
antibiot
prescrib
also
affect
level
resist
us
studi
found
lower
avail
primari
care
doctor
associ
inappropri
prescript
antibiot
upper
respiratori
tract
infect
suggest
busi
doctor
like
prescrib
antibiot
easi
way
rotat
rotat
empir
antibiot
remain
controversi
question
plo
medicin
review
metaanalysi
conclud
cycl
rotat
antibiot
associ
reduct
infect
resist
infect
similarli
review
metaanalysi
antibiot
stewardship
reduc
c
difficil
incid
yield
posit
outcom
world
cup
brazil
upcom
hajj
saudi
arabia
illustr
challeng
communic
diseas
identif
control
intern
event
lesson
previou
event
london
olymp
euro
footbal
championship
polandukrain
appli
current
futur
gather
accord
expert
comment
lancet
lancet
infecti
diseas
id
intern
collabor
crucial
recent
discoveri
addit
merscov
case
rais
question
transpar
report
could
signific
come
hajj
time
updat
compendium
strategi
prevent
healthcareassoci
infect
continu
ich
public
revis
guidelin
central
lineassoci
bloodstream
infect
meticillinresist
aureu
accompani
editori
rais
question
whether
vertic
ie
target
horizont
ie
univers
approach
way
go
report
shift
opinion
away
toward
socal
horizont
approach
support
move
away
pathogenbas
vertic
target
strategi
canadian
studi
report
relax
vancomycinresist
enterococci
vre
screen
isol
affect
rate
vre
infect
although
rate
colon
rose
sharpli
meanwhil
dramat
increas
vre
preval
report
multicentr
german
studi
howev
much
vertic
target
approach
reduc
carbapenemresist
enterobacteriacea
isra
postacut
care
hospit
need
embrac
new
technolog
continu
improv
patient
outcom
even
resourcelimit
set
patient
mobil
phone
surpris
issu
mobil
phone
remind
improv
attend
schedul
hiv
appoint
cameroon
lancet
id
random
control
trial
big
brother
watch
studi
us
oper
room
identifi
dismal
hand
hygien
complianc
rate
anesthesiologist
author
understand
question
attain
hand
hygien
recommend
set
sever
use
review
publish
recent
journal
american
medic
associ
jama
publish
handi
advic
task
write
editori
nejm
includ
comprehens
review
infect
pregnanc
colistin
polymyxin
b
often
mention
breath
similar
clinic
infecti
diseas
review
liken
pea
pod
chalk
chees
need
rapid
nucleic
acid
diagnost
review
journal
antimicrobi
chemotherapi
howev
jama
research
letter
suggest
threequart
doctor
ca
nt
calcul
posit
predict
valu
correctli
journal
hospit
infect
review
highlight
potenti
larg
unrecogn
role
freeliv
amoeba
provid
safehaven
hospit
pathogen
legionella
pneumophila
acinetobact
baumannii
virus
hospit
water
system
term
confer
british
societi
antimicrobi
chemotherapi
bsac
hold
seri
roundtabl
meet
antimicrobi
resist
late
final
journal
antimicrobi
chemotherapi
studi
found
uk
chief
medic
offic
announc
antibiot
resist
releas
us
center
diseas
control
prevent
antimicrobi
resist
threat
report
made
twitter
light
discuss
antibiot
